Cargando…

Texture analysis of T2-weighted cardiovascular magnetic resonance imaging to discriminate between cardiac amyloidosis and hypertrophic cardiomyopathy

BACKGROUND: To elucidate the value of texture analysis (TA) in detecting and differentiating myocardial tissue alterations on T2-weighted CMR (cardiovascular magnetic resonance imaging) in patients with cardiac amyloidosis (CA) and hypertrophic cardiomyopathy (HCM). METHODS: In this retrospective st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Shan, Shi, Ke, Zhang, Yi, Yan, Wei-Feng, Guo, Ying-Kun, Li, Yuan, Yang, Zhi-Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124433/ https://www.ncbi.nlm.nih.gov/pubmed/35597906 http://dx.doi.org/10.1186/s12872-022-02671-0

Ejemplares similares

Left ventricular global function index by magnetic resonance imaging — a novel marker for differentiating cardiac amyloidosis from hypertrophic cardiomyopathy
por: Huang, Shan, et al.
Publicado: (2020)

The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance
por: Noureldin, Radwa A, et al.
Publicado: (2012)

T2-weighted cardiac magnetic resonance image and myocardial biomarker in hypertrophic cardiomyopathy
por: Chen, Shi, et al.
Publicado: (2020)

Clinical Utility of Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy
por: Maron, Martin S
Publicado: (2012)

Cardiac amyloidosis and hypertrophic cardiomyopathy: A dangerous liaison
por: Ebrille, Elisa, et al.
Publicado: (2013)

Comparison of left ventricular global and segmental strain parameters by cardiovascular magnetic resonance tissue tracking in light-chain cardiac amyloidosis and hypertrophic cardiomyopathy
por: Wang, Fangqing, et al.
Publicado: (2022)

Amyloidosis with phenotype of hypertrophic cardiomyopathy
por: Kuryła, Martyna, et al.
Publicado: (2023)

The diagnostic value of multiparameter cardiovascular magnetic resonance for early detection of light-chain amyloidosis from hypertrophic cardiomyopathy patients
por: Yue, Xiuzheng, et al.
Publicado: (2022)

Cardiovascular Magnetic Resonance and prognosis in cardiac amyloidosis
por: Maceira, Alicia M, et al.
Publicado: (2008)

Cardiovascular magnetic resonance of mitral valve length in hypertrophic cardiomyopathy
por: Tarkiainen, Mika, et al.
Publicado: (2016)

Endogenous T1ρ cardiovascular magnetic resonance in hypertrophic cardiomyopathy
por: Thompson, Elizabeth W., et al.
Publicado: (2021)

The Role of Cardiovascular Magnetic Resonance Imaging in the Evaluation of Hypertrophic Cardiomyopathy
por: Sivalokanathan, Sanjay
Publicado: (2022)

Cardiac Amyloidosis Masked as Hypertrophic Cardiomyopathy: A Case Report
por: Wang, Jing, et al.
Publicado: (2016)

Cardiovascular magnetic resonance feature tracking strain analysis for discrimination between hypertensive heart disease and hypertrophic cardiomyopathy
por: Neisius, Ulf, et al.
Publicado: (2019)

Cardiac Magnetic Resonance and Computed Tomography in Hypertrophic Cardiomyopathy: an Update
por: de Oliveira, Diogo Costa Leandro, et al.
Publicado: (2016)

Cardiac magnetic resonance imaging in the evaluation of patients with hypertrophic cardiomyopathy
por: Brenes, Juan Carlos, et al.
Publicado: (2018)

Post-Mortem Cardiac Magnetic Resonance for the Diagnosis of Hypertrophic Cardiomyopathy
por: Aquaro, Giovanni Donato, et al.
Publicado: (2020)

Tumoral Phenocopies of Hypertrophic Cardiomyopathy: The Role of Cardiac Magnetic Resonance
por: Bombace, Sara, et al.
Publicado: (2021)

Myocardial Deformation in Cardiac Amyloid Light-chain Amyloidosis: Assessed with 3T Cardiovascular Magnetic Resonance Feature Tracking
por: Li, Rui, et al.
Publicado: (2017)

Distinguishing Cardiac Amyloidosis and Hypertrophic Cardiomyopathy by Thickness and Myocardial Deformation of the Right Ventricle
por: Liu, Hui, et al.
Publicado: (2022)

Cardiovascular magnetic resonance T2* mapping for the assessment of cardiovascular events in hypertrophic cardiomyopathy
por: Gastl, Mareike, et al.
Publicado: (2020)

Contrast-free detection of myocardial fibrosis in hypertrophic cardiomyopathy patients with diffusion-weighted cardiovascular magnetic resonance
por: Nguyen, Christopher, et al.
Publicado: (2015)

Reproducibility of in-vivo diffusion tensor cardiovascular magnetic resonance in hypertrophic cardiomyopathy
por: McGill, Laura-Ann, et al.
Publicado: (2012)

Cardiovascular Magnetic Resonance Imaging of Myocardial Interstitial Expansion in Hypertrophic Cardiomyopathy
por: Wong, Timothy C.
Publicado: (2014)

Cardiovascular magnetic resonance T2* mapping for structural alterations in hypertrophic cardiomyopathy
por: Gastl, Mareike, et al.
Publicado: (2019)

Contemporary family screening in hypertrophic cardiomyopathy: the role of cardiovascular magnetic resonance( )
por: Huurman, Roy, et al.
Publicado: (2022)

Diagnosis and Management of a Cardiac Amyloidosis Case Mimicking Hypertrophic Cardiomyopathy
por: Sattar, Yasar, et al.
Publicado: (2018)

Cardiac Sarcoidosis Mimicking Hypertrophic Cardiomyopathy: The Importance of Cardiac Magnetic Resonance Imaging
por: Feldman, Daniel R., et al.
Publicado: (2020)

Risk stratification in cardiomyopathies (dilated, hypertrophic, and arrhythmogenic cardiomyopathy) by cardiac magnetic resonance imaging
por: Guglielmo, Marco, et al.
Publicado: (2021)

Differentiating between cardiac amyloidosis and hypertrophic cardiomyopathy on non-contrast cine-magnetic resonance images using machine learning-based radiomics
por: Jiang, Shu, et al.
Publicado: (2022)

Assessing right ventricular deformation in hypertrophic cardiomyopathy patients with preserved right ventricular ejection fraction: a 3.0-T cardiovascular magnetic resonance study
por: Li, Xiang, et al.
Publicado: (2020)

The use of cardiac magnetic resonance imaging in diagnosing and characterizing hypertrophic cardiomyopathy
por: Ogele, Emmanuel, et al.
Publicado: (2016)

Role of Cardiac Magnetic Resonance in Detecting Biventricular Apical Hypertrophic Cardiomyopathy
por: Zaher, Nathan, et al.
Publicado: (2021)

Late gadolinium enhancement cardiovascular magnetic resonance for sudden cardiac death risk stratification in hypertrophic cardiomyopathy
por: Ismail, Tevfik F, et al.
Publicado: (2013)

The Value of Cardiac Magnetic Resonance Imaging in Identification of Rare Diseases Mimicking Hypertrophic Cardiomyopathy
por: Fang, Tingting, et al.
Publicado: (2021)

Correction: reproducibility of in-vivo diffusion tensor cardiovascular magnetic resonance in hypertrophic cardiomyopathy
por: McGill, Laura-Ann, et al.
Publicado: (2013)

Prevalence and characteristics of apical aneurysm on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy
por: Kim, Eun Kyoung, et al.
Publicado: (2014)

Regional myocardial microvascular dysfunction in cardiac amyloid light-chain amyloidosis: assessment with 3T cardiovascular magnetic resonance
por: Li, Rui, et al.
Publicado: (2016)

Findings of Cardiac Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy after 16 Years
por: Kim, Gee-Hee, et al.
Publicado: (2016)

Correlation of Electrocardiographic Changes with Cardiac Magnetic Resonance Findings in Patients with Hypertrophic Cardiomyopathy
por: Paixão, Gabriela Miana de Mattos, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_a79db56rfvnrofhoenrsscn5ee